about
Mechanisms of hypergammaglobulinemia and impaired antigen-specific humoral immunity in HIV-1 infectionMonophylogenetic HIV-1C epidemic in Ethiopia is dominated by CCR5-tropic viruses-an analysis of a prospective country-wide cohortOnly slight impact of predicted replicative capacity for therapy response predictionComparison of classifier fusion methods for predicting response to anti HIV-1 therapyLow prevalence of transmitted drug resistance in patients newly diagnosed with HIV-1 infection in Sweden 2003-2010Feasibility and effectiveness of indicator condition-guided testing for HIV: results from HIDES I (HIV indicator diseases across Europe study)Long-term efficacy of first line antiretroviral therapy in Indian HIV-1 infected patients: a longitudinal cohort studyTrends in antiretroviral therapy and prevalence of HIV drug resistance mutations in Sweden 1997-2011Molecular dating of HIV-1 subtype C from BangladeshHIV care in the Swedish-Danish HIV cohort 1995-2010, closing the gapsPatterns of transmitted HIV drug resistance in Europe vary by risk groupDecreased phenotypic susceptibility to etravirine in patients with predicted genotypic sensitivityMinority drug-resistant HIV-1 variants in treatment naïve East-African and Caucasian patients detected by allele-specific real-time PCRThe global spread of HIV-1 subtype B epidemic.HIV-1 fitness landscape models for indinavir treatment pressure using observed evolution in longitudinal sequence data are predictive for treatment failure.Time on drug analysis based on real life data.Quantitative humoral profiling of the HIV-1 proteome in elite controllers and patients with very long-term efficient antiretroviral therapy.Antiretroviral therapy optimisation without genotype resistance testing: a perspective on treatment history based modelsDrug resistance testing through remote genotyping and predicted treatment options in human immunodeficiency virus type 1 infected Tanzanian subjects failing first or second line antiretroviral therapy.Evaluation of sequence ambiguities of the HIV-1 pol gene as a method to identify recent HIV-1 infection in transmitted drug resistance surveysVirological failure in patients with HIV-1 subtype C receiving antiretroviral therapy: an analysis of a prospective national cohort in SwedenT-bet and Eomes are differentially linked to the exhausted phenotype of CD8+ T cells in HIV infectionMolecular epidemiology of HIV-1 subtypes in India: origin and evolutionary history of the predominant subtype C.Characterization of HIV-specific CD4+ T cell responses against peptides selected with broad population and pathogen coverage.Risk of HIV transmission from patients on antiretroviral therapy: a position statement from the Public Health Agency of Sweden and the Swedish Reference Group for Antiviral Therapy.Increase in transmitted resistance to non-nucleoside reverse transcriptase inhibitors among newly diagnosed HIV-1 infections in Europe.Kinetics of microbial translocation markers in patients on efavirenz or lopinavir/r based antiretroviral therapy.Severe functional impairment and elevated PD-1 expression in CD1d-restricted NKT cells retained during chronic HIV-1 infectionGut Microbiota Linked to Sexual Preference and HIV Infection.Clinical evaluation of Rega 8: an updated genotypic interpretation system that significantly predicts HIV-therapy response.Superinfection with drug-resistant HIV is rare and does not contribute substantially to therapy failure in a large European cohort.Antiretroviral treatment of human immunodeficiency virus infection: Swedish recommendations.Bilirubin-a potential marker of drug exposure in atazanavir-based antiretroviral therapyArming of MAIT Cell Cytolytic Antimicrobial Activity Is Induced by IL-7 and Defective in HIV-1 Infection.Gut microbiota diversity predicts immune status in HIV-1 infection.Multidimensional Clusters of CD4+ T Cell Dysfunction Are Primarily Associated with the CD4/CD8 Ratio in Chronic HIV InfectionImpact of HMGB1/TLR Ligand Complexes on HIV-1 Replication: Possible Role for Flagellin during HIV-1 Infection.Viral blips during suppressive antiretroviral treatment are associated with high baseline HIV-1 RNA levelsImpact of peer support on virologic failure in HIV-infected patients on antiretroviral therapy - a cluster randomized controlled trial in Vietnam.Treatment-associated polymorphisms in protease are significantly associated with higher viral load and lower CD4 count in newly diagnosed drug-naive HIV-1 infected patients
P50
Q28182419-97D965D6-AE55-44BC-8FE1-2719859C1F2BQ28365077-BF58744F-C1A6-4DBD-A10A-BE96C483FFFEQ28472749-079AC2B6-D52F-451C-A694-60EA486ECF1FQ28473854-2A10D8C3-56F5-4B84-8DB4-906104B8F5E0Q28481603-1FC20360-064D-4072-A13E-E51E5C09942AQ28485122-92AE2F8A-B695-4A81-B9CA-DA37BF030705Q28485373-B59B8362-93F3-498C-823F-C01C6580BCACQ28488769-07418090-2CA5-47DA-A6F7-54FC2CE7A755Q28534774-734DC02F-0DCC-4E53-BCD0-9EEB50CF15F3Q28535365-85AB9B33-BAB7-4C3E-B0B0-5092847BB453Q28537726-054CE1A8-1FCF-48E1-8389-A93E63A4968BQ28540368-CE0D0DEF-D084-4D47-B224-763C063DC4CAQ28543986-87C208FA-049C-459A-AAD7-1447392D1871Q30388926-4C250E33-D35A-4DE7-BAAD-265FF232066FQ30605804-46638E92-AAA4-47F0-AB56-C3D33FE3F946Q30869858-CBF79D6D-73C9-4E4D-9EDD-C63574230F78Q33677727-05257BA2-1433-47D8-B443-FB613DB1619DQ33741902-D296E8E0-F590-4693-BD8F-C39C00A60FC1Q33764793-59DE338F-FC2E-45B3-8D6E-F85B0326BCC2Q33791635-5A82B613-F1D0-4E5D-AC2E-A3BCA5028135Q33856712-41E43ABF-5257-4A8C-9484-8E74C5AAA10EQ33916550-7CF53051-BF72-4DEE-88B4-5EF4D6E22B67Q34328297-FA190844-12EB-4CDF-B553-E6136392A28EQ34335751-6A820ED9-BB57-4A0E-B9CC-CF5807FD014BQ34336508-C54A08F8-69F8-4B1A-9FEF-AA01537A4E1DQ34469240-52176E91-AB49-479F-B3A9-2BB869EA6717Q34575989-9A5A9A69-E3AB-4623-B1D8-6035ECF4E191Q34604276-9A57A839-5578-4F90-817B-CFDF66F6D08DQ34676893-F6D6C3F1-12DC-4A2A-B63F-BC7AC65E030DQ34684386-50098499-F654-442A-872C-8C2BD16D88ADQ35039280-F80190E0-6402-48BD-B332-360496FE32ECQ35129194-EFABAF20-7C0C-4C85-8BF4-48F8C6DC7631Q35595787-5B52C980-9F41-4B8D-9E83-960E30A10CC3Q35752258-2379E097-D5AF-49D5-B4D8-176F2FF882A2Q35768934-D5A607D1-DF01-4C60-8633-F920C3A7ADDFQ35786633-71C20C4C-0D78-4788-A935-983C1D189300Q36032021-0CFFBFA0-DD4D-4C3C-918F-C90449FF92A8Q36058328-E79FA973-05EC-497B-BBE3-ABC05D1160E6Q36226907-544B9959-7CED-4041-8DD6-A5767B274583Q36367759-F8602E49-D470-44DB-841B-BC0C8175CC9A
P50
description
professor clinical virology
@en
professor klinisk virologi
@sv
name
Anders Sönnerborg
@en
Anders Sönnerborg
@nl
Anders Sönnerborg
@sv
type
label
Anders Sönnerborg
@en
Anders Sönnerborg
@nl
Anders Sönnerborg
@sv
prefLabel
Anders Sönnerborg
@en
Anders Sönnerborg
@nl
Anders Sönnerborg
@sv
P214
P106
P2038
Anders_Soennerborg